27/10/2025
GPN Vaccines Inc Completes Acquisition of BacVax Inc.
New York, USA – 24th October 2025 GPN Vaccines Inc (“GPN”) is pleased to announce it has successfully…
Blog
- Read article
19/09/2025GPN Vaccines announces changes to its Board of Directors
Read articleNew York, USA – 19th September 2025 GPN Vaccines Inc (USA) today announces the retirement of Prof. James…
08/09/2025GPN Vaccines receives $4.7 million R&D Tax Incentive refund
Read articleNew York, USA – 8th September 2025 GPN Vaccines is pleased to announce it has received AU$4.7 million…
25/07/2025GPN Vaccines Inc Acquires GPN Vaccines Ltd
Read articleNew York, USA and Adelaide, Australia – 25th July 2025 GPN Vaccines Inc, a Delaware C-corporation, formally announces…
14/07/2025GPN Vaccines reports strong immunogenicity data in older adults independent of previous pneumococcal vaccination status with good tolerability and sustained immunogenicity
Read articleAdelaide, Australia, 14th July 2025 GPN Vaccines Ltd, a clinical-stage biotechnology company developing a Streptococcus pneumoniae vaccine to…
12/06/2025Notice to Scheme Shareholders
Read articleOn 12 June 2025, GPN AUS and GPN USA signed a Deed of Variation to the Scheme Implementation…
- 27/05/2025
GPN Vaccines Shareholders Vote in Favour of Re-domiciliation of the Company to the United States of America; Notice of Hearing to Approve Scheme of Arrangement
Read articleCanberra, Australia, 27th May 2025 GPN Vaccines Ltd is pleased to announce the Company’s shareholders have voted unanimously…
15/02/2023How GPN Vaccines is outsmarting the pneumococcus
Read articleGPN Vaccines was initially established with the goal of creating a vaccine capable of protecting children and adults…
20/09/2022Landmark Publication shows Gamma-PN Elicits Opsonophagocytic Antibodies
Read articleAdelaide, Australia, 21st September 2022 – GPN Vaccines is pleased to announce publication of a landmark scientific paper…
24/01/2020GPN Vaccines Changes Status to a Public Company Limited by Shares
Read articleAdelaide, Australia, 24 January 2020 – GPN Vaccines announces that it has changed its status from a Private Company…
21/05/2019Publication in Nature Microbiology
Read articleAdelaide, Australia, 21 May 2019 – Gamma-PN boosts the immune systems’ response to flu vaccination GPN Vaccines’ serotype-independent pneumococcal…